Determining an appropriate treatment through precision medicine requires inspection of crucial novel biomarkers from tissue samples or liquid biopsies such as plasma/serum, sputum, saliva, urine, and cerebrospinal fluid for earlier disease diagnosis and prognosis. Analysis of non-coding RNA such as microRNA (miRNA) and long noncoding RNA (lncRNA), DNA methylation, and posttranslational histone modifications are epigenetic […]